West Branch Capital’s Chemours CC Stock Holding History

West Branch Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16	Closed	–	–	458
2022 Q3	$0	Hold	16	–	–	﹤0.01%	444
2022 Q2	$1K	Hold	16	–	–	﹤0.01%	396
2022 Q1	$1K	Hold	16	–	–	﹤0.01%	398
2021 Q4	$1K	Hold	16	–	–	﹤0.01%	424
2021 Q3	$0	Buy	+16	New	+$518	﹤0.01%	427

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

West Branch Capital's CC Position: Q4 2022 in Review

West Branch Capital sold out of Chemours (CC) in Q4 2022, closing a stake of 16 shares.

West Branch Capital first reported a position in CC in Q3 2021 and held it in 5 quarters. The position peaked at $1K in Q2 2022. 474 funds tracked by Wall St. Rank hold CC as of Q4 2022.

West Branch Capital reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
West Branch Capital sold 16 Chemours shares in Q4 2022.
West Branch Capital first reported a position in Chemours in Q3 2021 and held it in 5 quarters.
West Branch Capital's Chemours position peaked at $1K in Q2 2022.
474 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on West Branch Capital's 13F filing for Q4 2022, filed 27 Jan 2023.